This Elsevier journal publishes expert critical reviews across all of oncology and haematology and is the official journal of the European School of Oncology. Clinicians and trainees read it for structured overviews of a field.
Critical Reviews in Oncology/Hematology publishes scholarly, critical reviews in all fields of oncology and haematology written by experts from around the world, and is the official journal of the European School of Oncology (ESO) and of the International Society of Liquid Biopsy. Its sections include basic experimental oncology, career development and education, clinical research, global oncology, haematology, immunotherapy, molecular pathology, genomics and liquid biopsy, palliative and supportive care, paediatric oncology, radiotherapy, regulatory, ethics and health policy, solid tumours, statistics, meta-analysis and clinical trial design, and surgery. All review articles, whether invited or submitted spontaneously, undergo peer review before acceptance. The access model is not stated in the pages consulted and is not recorded here. NLM records the title from 1983, first published by CRC Press in Boca Raton and from 2005 by Elsevier in Amsterdam, twelve issues a year, indexed in MEDLINE and PubMed. Not listed in DOAJ.
Health manager who leads the IRCCS Istituto Tumori Giovanni Paolo II in Bari, first as Direttore Generale and, since 2025, as Commissario Straordinario.
Colorectal surgeon and ESSO President, internationally known for watch-and-wait organ preservation in rectal cancer.
Marco Guzzo is a head and neck surgeon at INT Milan.
Nuclear medicine physician who directs Centre Henri Becquerel, the comprehensive cancer centre for the Rouen area in Normandy.
India's Drugs Controller General, who heads the Central Drugs Standard Control Organisation, the national regulator for medicines, medical devices and clinical trials.
Shares Pierre Vera, PubMed & Europe PMC.